4//SEC Filing
Vishnubhatla Suresh 4
Accession 0001209191-17-064762
CIK 0001388195other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 5:00 PM ET
Size
13.3 KB
Accession
0001209191-17-064762
Insider Transaction Report
Form 4
Vishnubhatla Suresh
SVP and CTO
Transactions
- Disposition to Issuer
Employee Stock Options
2017-12-07$18.41/sh−20,719$381,437→ 0 totalExercise: $10.84Exp: 2018-03-25→ Common Stock, par value $0.01 per share (20,719 underlying) - Award
Performance share units
2017-12-07+41,758→ 41,758 totalExercise: $0.00→ Common Stock, par value $0.01 per share (41,758 underlying) - Disposition to Issuer
Common Stock, $0.01 par value
2017-12-07$29.25/sh−67,031$1,960,657→ 0 total - Disposition to Issuer
Performance share units
2017-12-07−41,758→ 0 totalExercise: $0.00→ Common Stock, par value $0.01 per share (41,758 underlying)
Footnotes (4)
- [F1]Pursuant to the terms of the Agreement and Plan of Merger, dated as of August 1, 2017 (the "Merger Agreement"), by and among PharMerica Corporation (the "Company"), Phoenix Parent Holdings Inc., a Delaware corporation ("Parent"), and Phoenix Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent, at the effective time ("Effective Time") of the merger, Merger Sub will merge with and into the Company, with the Company as the surviving entity and a wholly owned subsidiary of Parent.
- [F2]Pursuant to the terms of the Merger Agreement, as of the Effective Time (i) each shares of the Company's common stock, par value $0.01 per share ("Company Common Stock") owned and (ii) each outstanding restricted stock unit granted by the Company was converted automatically into a right to receive an amount in cash without interest equal to the product of (x) the number of shares of Company Common Stock subject to such unit, such number of shares based on target performance in the case of performance stock units, multiplied by (y) the Merger Consideration.
- [F3]The options vested in the following amounts on the following dates: 5,179 options on 03/25/2012, 5,179 options on 03/25/2013, 5,180 options on 03/25/2014 and 5,181 options on 03/25/2015.
- [F4]Pursuant to the Merger Agreement, at the Effective Time, each outstanding employee option, whether vested or unvested ("Company Stock Option") became fully vested and was converted automatically into the right to receive an amount in cash without interest equal to the product of (x) the number of shares of Company Common Stock subject to such Company Stock Option, multiplied by (y) the excess, if any, of the Merger Consideration over the exercise price per share of such Company Stock Option.
Documents
Issuer
PharMerica CORP
CIK 0001388195
Entity typeother
Related Parties
1- filerCIK 0001516295
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 5:00 PM ET
- Size
- 13.3 KB